The reader is invited to consult the original guidelines for more detailed information. Heart Failure Criteria, Classification, and Staging Guideline contributor: Henry H Ooi, MD, MRCPI, Director, Advanced Heart Failure and Cardiac Transplant Program, Nashville Veterans Affairs Medical Center; Assistant...
Updated and revised guidelines on the management of heart failure (HF) were published in May 2022 by the American College of Cardiology, American Heart Association, and Heart Failure Society of America (ACC/AHA/HFSA) in Circulation. These guidelines replace the 2013 and 2017 recommendations with ...
Areas of focus in the 2022 heart failure (HF) guidelines are the prevention of HF and the new treatment strategies in HF using contemporary approaches to care. Influenza vaccination, a key nonpharmacologic intervention tested in a large cohort of HF patients including Nigerians, could significantly...
“Heart failure is a disease that will increase explosively in the future aging population,” KFHS Chairman Kang Seok-min said during a press conference on Friday. “Fortunately, since the KFHS published its first revised domestic heart failure treatment guidelines, various new drugs and various ...
Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial. Lancet. 2019;393(10166):61-73. doi:10.1016/S0140-6736(18)32484-X 6. Neal B, Perkovic V, Mahaffey KW, et al; CANVAS Prog...
Heart failure with mildly reduced ejection fraction (HFmrEF) is the new definition for heart failure (HF) with left ventricular ejection fraction (LVEF) between 41% and 49% in the 2021 ESC Guidelines for the diagnosis and...
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic... Corrigendum to: ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. The Task Force for the Diagnosis...
this study aimed to investigate the impact of GDMT prescription at the time of M-TEER treatment on survival and whether such impact differs based on chronic kidney disease (CKD), HF aetiology, and residual mitral regurgitat...
Tab.2 Summary of recommended drugs for chronic heart failure treatment in domestic and international guidelines 表2 国内外指南慢性心衰治疗药物推荐汇总 中国:《中国心力衰竭诊断和治疗指南2024》;美国:《2022 AHA/ACC/ HFSA心力衰竭的管理指南》;欧洲:《2021 ESC急性和慢性心力衰竭诊断和治疗指南及2023更新版》...
Therefore, there are well- established classes of drugs – ACEi, beta- blockers, MRAs – that should be used as first line treatment in all patients with heart failure. In the past few years newer therapeutic approaches have been shown to improve prognosis in patients with heart failure but,...